Chengyi Mao

953 total citations
30 papers, 728 citations indexed

About

Chengyi Mao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chengyi Mao has authored 30 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chengyi Mao's work include Esophageal Cancer Research and Treatment (7 papers), RNA modifications and cancer (6 papers) and Cancer Cells and Metastasis (5 papers). Chengyi Mao is often cited by papers focused on Esophageal Cancer Research and Treatment (7 papers), RNA modifications and cancer (6 papers) and Cancer Cells and Metastasis (5 papers). Chengyi Mao collaborates with scholars based in China, United States and Taiwan. Chengyi Mao's co-authors include Zonglong Zhu, Chu‐Chen Chueh, Nan Li, Alex K.‐Y. Jen, Yu‐Shang Yang, Yong Yuan, Xiaoxi Zeng, Siyuan Luan, Hualiang Xiao and Jianfeng Zhou and has published in prestigious journals such as Advanced Materials, PLoS ONE and Scientific Reports.

In The Last Decade

Chengyi Mao

29 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengyi Mao China 14 284 231 136 131 129 30 728
Kai Chio Chan United Kingdom 13 187 0.7× 65 0.3× 45 0.3× 335 2.6× 78 0.6× 14 719
Xiaojuan Wu China 9 139 0.5× 92 0.4× 30 0.2× 139 1.1× 226 1.8× 17 587
Xinliang Zhou China 11 199 0.7× 144 0.6× 42 0.3× 103 0.8× 62 0.5× 20 476
Hena Zhang China 14 463 1.6× 106 0.5× 30 0.2× 41 0.3× 205 1.6× 37 807
Jason D. Howard United States 13 206 0.7× 301 1.3× 12 0.1× 147 1.1× 72 0.6× 29 673
Xianliang Hou China 16 158 0.6× 45 0.2× 41 0.3× 85 0.6× 81 0.6× 54 674
Xiaotian Sun China 7 519 1.8× 133 0.6× 77 0.6× 116 0.9× 22 0.2× 10 754
Se Yeon Park South Korea 12 249 0.9× 90 0.4× 16 0.1× 39 0.3× 93 0.7× 19 646
Zhangfu Yang China 18 288 1.0× 130 0.6× 7 0.1× 139 1.1× 192 1.5× 44 795

Countries citing papers authored by Chengyi Mao

Since Specialization
Citations

This map shows the geographic impact of Chengyi Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyi Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyi Mao more than expected).

Fields of papers citing papers by Chengyi Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyi Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyi Mao. The network helps show where Chengyi Mao may publish in the future.

Co-authorship network of co-authors of Chengyi Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyi Mao. A scholar is included among the top collaborators of Chengyi Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyi Mao. Chengyi Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Hong, Xiaoyan Dai, Xiao He, et al.. (2023). E3 ubiquitin ligase TRIM21 targets TIF1γ to regulate β-catenin signaling in glioblastoma. Theranostics. 13(14). 4919–4935. 20 indexed citations
2.
Zhu, Jingyi, Xi Zhang, Xiao Zheng, et al.. (2022). Dry eye symptoms in interferon regulatory factor 3-deficient mice due to herpes simplex virus infection in harderian gland and lacrimal gland. Experimental Eye Research. 219. 109053–109053. 6 indexed citations
3.
Li, Xiaokun, Lingmin Chen, Siyuan Luan, et al.. (2022). The development and progress of nanomedicine for esophageal cancer diagnosis and treatment. Seminars in Cancer Biology. 86(Pt 2). 873–885. 76 indexed citations
4.
Jiang, Hao, Wei Xing, Shao‐Chuan Wang, et al.. (2022). A Clinical Diagnostic Study: Fibulin-2 is a Novel Promising Biomarker for Predicting Infection. Infectious Diseases and Therapy. 11(3). 1057–1073. 3 indexed citations
5.
Liu, Jun, Jingkun Wang, Hongyi Xiang, et al.. (2022). Research on skeletal muscle impact injury using a new rat model from a bioimpact machine. Frontiers in Bioengineering and Biotechnology. 10. 1055668–1055668. 8 indexed citations
6.
Jiang, Shasha, Xiaoyang Wang, Bin Jiang, et al.. (2021). BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma. International Journal of Biological Sciences. 17(10). 2461–2475. 9 indexed citations
7.
Wang, Qiushi, Mengxia Li, Xiao Yang, et al.. (2021). Case Report and Literature Review: Pulmonary Sclerosing Pneumocytoma With Multiple Metastases Harboring AKT1 E17K Somatic Mutation and TP53 C176Y Germline Mutation. Frontiers in Medicine. 8. 655574–655574. 3 indexed citations
8.
Mao, Chengyi, Xiaoxi Zeng, Chao Zhang, et al.. (2021). Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer. Frontiers in Cell and Developmental Biology. 9. 612451–612451. 26 indexed citations
9.
10.
Mao, Chengyi, et al.. (2019). Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma. Thoracic Cancer. 10(11). 2071–2080. 4 indexed citations
11.
Zhang, Liang, Mengxia Li, Bo Deng, et al.. (2019). <p>HLA-DQB1 expression on tumor cells is a novel favorable prognostic factor for relapse in early-stage lung adenocarcinoma</p>. Cancer Management and Research. Volume 11. 2605–2616. 16 indexed citations
12.
Han, Fei, Xiao Jiang, Zhiming Li, et al.. (2019). Epigenetic Inactivation of SOX30 Is Associated with Male Infertility and Offers a Therapy Target for Non-obstructive Azoospermia. Molecular Therapy — Nucleic Acids. 19. 72–83. 22 indexed citations
13.
Mao, Chengyi, Yu‐Shang Yang, Yong Yuan, et al.. (2019). End-to-End Versus End-to-Side Hand-Sewn Anastomosis for Minimally Invasive McKeown Esophagectomy. Annals of Surgical Oncology. 26(12). 4062–4069. 10 indexed citations
14.
Zhao, Lianhua, Chuan Chen, Chengyi Mao, et al.. (2019). Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors. Pathology - Research and Practice. 215(7). 152448–152448. 19 indexed citations
15.
Zhao, Lianhua, Chengyi Mao, He Xiao, et al.. (2019). Simultaneous expression of TTF1 and GATA3 in a lung biopsy sample: confusion in diagnostic pathology.. PubMed. 12(9). 3613–3619. 5 indexed citations
16.
Wang, Tao, Hong Wu, Sha Liu, et al.. (2018). SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance. Cancer Letters. 430. 11–24. 47 indexed citations
17.
Zhu, Zonglong, Chu‐Chen Chueh, Nan Li, Chengyi Mao, & Alex K.‐Y. Jen. (2017). Realizing Efficient Lead‐Free Formamidinium Tin Triiodide Perovskite Solar Cells via a Sequential Deposition Route. Advanced Materials. 30(6). 234 indexed citations
18.
19.
Han, Fei, Wenbin Liu, Hualiang Xiao, et al.. (2015). High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma. Scientific Reports. 5(1). 13630–13630. 27 indexed citations
20.
Yu, Yanyan, Bin Wang, Kun Zhang, et al.. (2013). High expression of lysine-specific demethylase 1 correlates with poor prognosis of patients with esophageal squamous cell carcinoma. Biochemical and Biophysical Research Communications. 437(2). 192–198. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Chio Chan Breakdown of academic impact, for papers by Xiaojuan Wu Breakdown of academic impact, for papers by Xinliang Zhou Breakdown of academic impact, for papers by Hena Zhang Breakdown of academic impact, for papers by Jason D. Howard Breakdown of academic impact, for papers by Xianliang Hou Breakdown of academic impact, for papers by Xiaotian Sun Breakdown of academic impact, for papers by Se Yeon Park Breakdown of academic impact, for papers by Zhangfu Yang
Rankless by CCL
2026